Tissue distribution and metabolism of guanosine in rats following intraperitoneal injection

Journal of Biological Regulators and Homeostatic Agents

Volumn 26, Issue 1, 2012, Pages 51-65

  Giuliani, P ^a   Ballerini, P ^a   Ciccarelli, R ^a   Buccella, S ^a   Romano, S ^a   D'Alimonte, I ^a   Poli, A ^b   Beraudi, A ^b   Pena E ^b   Jiang, S ^c   Rathbone, M P ^c   Caciagli, F ^a   Di Iorio, P ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Distribution; Guanine; Guanine based purine release; Guanosine; Guanosine guanine uptake; Metabolism

Indexed keywords

GUANINE; GUANOSINE; URIC ACID; XANTHINE;

ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG ACTIVITY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG METABOLISM; DRUG TISSUE LEVEL; ENZYME ACTIVITY; ENZYME ANALYSIS; HEART; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY; LIQUID SCINTILLATION COUNTING; LIVER; LUNG; MALE; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; RADIOACTIVITY; RADIOCHEMISTRY; RAT; TISSUE HOMOGENATE; ULTRAVIOLET RADIATION;

ANIMALS; ASTROCYTES; BRAIN; CELLS, CULTURED; GUANINE; GUANOSINE; INJECTIONS, INTRAPERITONEAL; KIDNEY; LIVER; LUNG; MALE; MYOCARDIUM; PURINE-NUCLEOSIDE PHOSPHORYLASE; PURINES; RATS; RATS, SPRAGUE-DAWLEY; XANTHINE;

RATTUS;

EID: 84859882118     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Parpura V, Zorec R. Gliotransmission: Exocytotic release from astrocytes. Brain Res Rev 2010; 63(1-2):83-92.
2. Fields RD. Nonsynaptic and nonvesicular ATP release from neurons and relevance to neuron-glia signaling. Semin Cell Dev Biol 2011; 22:214-19.
3. Schmidt AP, Lara DR, Souza DO. Proposal of a guanine-based purinergic system in the mammalian central nervous system. Pharmacol Ther 2007; 116(3):401-16. (Pubitemid 350116938)
4. Ciccarelli R, Di Iorio P, Giuliani P, D'Alimonte I, Ballerini P, Caciagli F, Rathbone MP. Rat cultured astrocytes release guanine-based purines in basal conditions and after hypoxia/hypoglycemia. Glia 1999; 25(1):93-8. (Pubitemid 28554059)
5. Caciagli F, Di Iorio P, Giuliani P, Middlemiss MP, Rathbone MP. The neuroprotective activity of guanosine involves the production of trophic factors and the outflow of purines from astrocytes. Drug Dev Res 2000; 50:32.
6. Frizzo ME, Lara DR, Prokopiuk Ade S, Vargas CR, Salbego CG, Wajner M, Souza DO. Guanosine enhances glutamate uptake in brain cortical slices at normal and excitotoxic conditions. Cell Mol Neurobiol 2002; 22(3):353-63. (Pubitemid 35364892)
7. Frizzo ME, Antunes Soares FA, Dall'Onder LP, Lara DR, Swanson RA, Souza DO. Extracellular conversion of guanine-based purines to guanosine specifically enhances astrocyte glutamate uptake. Brain Res 2003; 972(1-2):84-9. (Pubitemid 36507080)
8. Jiang S, Khan MI, Lu Y, Wang J, Buttigieg J, Werstiuk ES, Ciccarelli R, Caciagli F, Rathbone MP. Guanosine promotes myelination and functional recovery in chronic spinal injury. Neuroreport 2003; 14(18):2463-7.
9. Su C, Elfeki N, Ballerini P, D'Alimonte I, Bau C, Ciccarelli R, Caciagli F, Gabriele J, Jiang S. Guanosine improves motor behavior, reduces apoptosis, and stimulates neurogenesis in rats with parkinsonism. J Neurosci Res 2009; 87(3):617-25.
10. de Oliveira DL, Horn JF, Rodrigues JM, Frizzo ME, Moriguchi E, Souza DO, Wofchuk S. Quinolinic acid promotes seizures and decreases glutamate uptake in young rats: reversal by orally administered guanosine. Brain Res 2004; 1018(1):48-54. (Pubitemid 38942860)
11. Torres FV, da Silva Filho M, Antunes C, Kalinine E, Antoniolli E, Portela LV, Souza DO, Tort AB. Electrophysiological effects of guanosine and MK-801 in a quinolinic acid-induced seizure model. Exp Neurol 2010; 221(2):296-306.
12. Schmidt AP, Böhmer AE, Schallenberger C, Antunes C, Tavares RG, Wofchuk ST, Elisabetsky E, Souza DO. Mechanisms involved in the antinociception induced by systemic administration of guanosine in mice. Br J Pharmacol 2010; 159(6):1247-63.
13. Schmidt AP, Paniz L, Schallenberger C, Böhmer AE, Wofchuk ST, Elisabetsky E, Portela LV, Souza DO. Guanosine prevents thermal hyperalgesia in a rat model of peripheral mononeuropathy. J Pain 2010; 11(2):131-41.
14. Gudkov SV, Gudkova OIu, Shtarkman IN, Gapeev AB, Chemeris NK, Bruskov VI. Guanosine and inosine as natural geneprotectors for mice blood cells exposed to X-rays. Radiats Biol Radioecol 2006; 46(6):713-8.
15. Soares FA, Schmidt AP, Farina M, Frizzo ME, Tavares RG, Portela LV, Lara DR, Souza DO. Anticonvulsant effect of GMP depends on its conversion to guanosine. Brain Res 2004; 1005(1-2):182-6. (Pubitemid 38388411)
16. Vinadé ER, Schmidt AP, Frizzo ME, Portela LV, Soares FA, Schwalm FD, Elisabetsky E, Izquierdo I, Souza DO. Effects of chronic administered guanosine on behavioral parameters and brain glutamate uptake in rats. J Neurosci Res 2005; 79(1-2):248-53. (Pubitemid 40116442)
17. Jiang S, Ballerini P, Buccella S, Giuliani P, Jiang C, Huang X, Rathbone MP. Remyelination after chronic spinal cord injury is associated with proliferation of endogenous adult progenitor cells after systemic administration of guanosine. Purinergic Signal 2008; 4(1):61-71.
18. Bzowska A, Kulikowska E, Shugar D. Purine nucleoside phosphorylases: properties, functions, and clinical aspects. Pharmacol Therapeut 2000; 88:349-425. (Pubitemid 32406058)
19. Gray JH, Owen RP, Giacomini KM. The concentrative nucleoside transporter family, SLC28. Pflugers Arch 2004; 447(5):728-34. (Pubitemid 38241458)
20. Robillard KR, Bone DB, Hammond JR. Hypoxanthine uptake and release by equilibrative nucleoside transporter 2 (ENT2) of rat microvascular endothelial cells. Microvasc Res 2008; 75(3):351-7. (Pubitemid 351508283)
21. De Keyser J, Mostert JP, Koch MW. Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders. J Neurol Sci 2008; 267(1-2):3-16. (Pubitemid 351248899)
22. Di Iorio P, Ballerini P, Traversa U, et al. The antiapoptotic effect of guanosine is mediated by the activation of the PI 3-kinase/AKT/PKB pathway in cultured rat astrocytes. Glia 2004; 46(4):356-68. (Pubitemid 38679194)
23. Yamamoto T, Moriwaki Y, Takahashi S, Nasako Y, Yamakita J, Hiroishi K, Higashino K. Determination of plasma purine nucleoside phosphorylase activity by high-performance liquid chromatography. Anal Biochem 1995; 227(1):135-9.
24. Shin DH, Choi KS, Cho BS, Song S, Moon DC, Hong JT, Lee CK, Chung YB. Pharmacokinetics of guanosine in rats following intravenous or intramuscular administration of a 1:1 mixture of guanosine and acriflavine, a potential antitumor agent. Arch Pharm Res 2008; 31(10):1347-53.
25. Nagasawa K, Kawasaki F, Tanaka A, Nagai K, Fujimoto S. Characterization of guanine and guanosine transport in primary cultured rat cortical astrocytes and neurons. Glia 2007; 55(14):1397-404. (Pubitemid 47461155)
26. Pettifer KM, Jiang S, Bau C, Ballerini P, D'Alimonte I, Werstiuk ES, Rathbone MP. MPP(+)-induced cytotoxicity in neuroblastoma cells: Antagonism and reversalby guanosine. Purinergic Signal 2007; 3(4):399-409.
27. Tarozzi A, Merlicco A, Morroni F, et al. Guanosine protects human neuroblastoma cells from oxidative stress and toxicity induced by Amyloid-beta peptide oligomers. J Biol Regul Homeost Agents 2010; 24(3):297-306.
28. Gerrikagoitia I, Martínez-Millán L. Guanosine-induced synaptogenesis in the adult brain in vivo. Anat Rec (Hoboken) 2009; 292(12):1968-75.
29. Jiang S, Zavitz CC, Wang J, et al. Non-adenine based purines accelerate wound healing. Purinergic Signal 2006; 2(4):651-61. (Pubitemid 44848676)
30. Di Iorio P, Caciagli F, Giuliani P, et al. Purine nucleosides protect injured neurons and stimulate neuronal regeneration by intracellular and membrane receptor-mediated mechanisms. Drug Dev Res 2001; 52(1-2): 303-15. (Pubitemid 32401953)
31. Traversa U, Bombi G, Di Iorio P, Ciccarelli R, Werstiuk ES, Rathbone MP. Specific [(3)H]-guanosine binding sites in rat brain membranes. Br J Pharmacol 2002; 135(4):969-76. (Pubitemid 34214456)
32. Garozzo R, Sortino MA, Vancheri C, Condorelli DF. Antiproliferative effects induced by guanine-based purines require hypoxanthine-guanine phosphoribosyltransferase activity. Biol Chem 2010; 391(9):1079-89.
33. Sidi Y, Panet C, Cyjon A, Fenig E, Beery E, Nordenberg J. Guanosine potentiates the antiproliferative effect of cytosine-beta-D-arabinofuranoside in melanoma cell lines. Cancer Invest 1993; 11(5):523-9. (Pubitemid 23281848)
34. Keilin J. The biological significance of uric acid and guanine excretion. Biol Rev Camb Philos Soc 1959; 34:265-96.
35. Khalpey Z, Yuen AH, Lavitrano M, McGregor CG, Kalsi KK, Yacoub MH, Smolenski RT. Mammalian mismatches in nucleotide metabolism: implications for xenotransplantation. Mol Cell Biochem 2007; 304(1-2):109-17. (Pubitemid 47456857)
36. Su C, Elfeki N, Ballerini P, D'Alimonte I, Bau C, Ciccarelli R, Caciagli F, Gabriele J, Jiang S. Guanosine improves motor behavior, reduces apoptosis, and stimulates neurogenesis in rats with parkinsonism. J Neurosci Res 2009; 87(3):617-25.
37. Kelly KJ, Plotkin Z, Dagher PC. Guanosine supplementation reduces apoptosis and protects renal function in the setting of ischemic injury. J Clin Invest 2001; 108(9):1291-8. (Pubitemid 33107756)
38. Kovács Z, Kékesi KA, Bobest M, et al. Post mortem degradation of nucleosides in the brain: comparison of human and rat brains for estimation of in vivo concentration of nucleosides. J Neurosci Methods 2005; 148(1):88-93. (Pubitemid 41423462)
39. Zamzow CR, Xiong W, Parkinson FE. Astrocytes affect the profile of purines released from cultured cortical neurons. J Neurosci Res 2008; 86(12):2641-9.
40. Schmidt AP, Böhmer AE, Leke R, et al. Antinociceptive effects of intracerebroventricular administration of guanine-based purines in mice: evidences for the mechanism of action. Brain Res 2008; 1234:50-8.